JAMA Network
About the Study: This Research Letter describes the incidence and quality of active surveillance use for prostate cancer in the national Veterans Affairs Healthcare System. In the VA health system, active surveillance or watchful waiting for favorable-risk prostate cancer increased from 27% to 93% for low-risk disease and from 14% to 61% for favorable intermediate-risk disease. Overall, the study suggests that many veterans with favorable-risk prostate cancer are avoiding unnecessary treatment, but some disparities in care still need attention.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
